235 POSTER Preclinical and clinical monitoring of cell-and circulating plasma specific proteasome biomarkers after treatment with the proteasome inhibitor, NPI-0052
M.A. Palladino, T. Chao, S.T.C. Neuteboom, M. Spear, W. Ma, M. AlbitarVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72167-0
File:
PDF, 59 KB
english, 2008